Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,43719,1782,1.04 [0.93-1.16],0.5236173762535403
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,43022,427,1.23 [0.99-1.52],0.0608118408179461
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,47771,326,1.01 [0.78-1.30],0.9498374294420652
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,33038,1554,1.09 [0.96-1.23],0.1746813001546564
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,47665,220,0.97 [0.71-1.34],0.8748435763031326
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,44593,172,1.08 [0.76-1.53],0.6721263898531191
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",50118,218,0.98 [0.72-1.35],0.923559295822202
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,50122,147,0.79 [0.53-1.18],0.2502680044447476
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,43553,118,1.57 [1.11-2.22],0.0114461797970616
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,48494,236,0.99 [0.73-1.33],0.925246217315284
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Other septicaemia,48411,153,1.10 [0.76-1.58],0.6117957803086991
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,50281,137,1.16 [0.80-1.68],0.4455102655225011
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Other viral diseases,50273,161,1.10 [0.77-1.57],0.6017597594458239
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",50262,150,1.05 [0.73-1.53],0.7838118891003742
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Mycoses,49602,104,0.96 [0.60-1.51],0.8496874847008948
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",47863,811,1.11 [0.95-1.30],0.2000220762980722
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,47331,279,1.06 [0.80-1.39],0.6936328373444551
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,47607,555,1.15 [0.95-1.39],0.1489919224008648
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)",40316,125,1.10 [0.73-1.65],0.6389691494288067
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",40303,112,0.94 [0.60-1.47],0.7717517364346084
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",40702,511,1.10 [0.90-1.35],0.3637581407625808
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",40716,525,1.09 [0.89-1.33],0.4066973471133316
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",22811,659,1.18 [0.99-1.40],0.0594144454848656
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",18267,228,1.15 [0.85-1.56],0.3598012287185173
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",40295,104,1.32 [0.88-1.99],0.1832821705744008
CEBPB,CCAAT/enhancer-binding protein beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,44917,1558,0.97 [0.86-1.10],0.6760777347856277
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",47779,642,0.91 [0.75-1.10],0.3180223089282911
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,49388,227,0.99 [0.73-1.35],0.9657954563322952
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",50439,212,0.87 [0.63-1.21],0.4016096176469014
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Benign neoplasm: Rectum,49894,128,0.97 [0.64-1.46],0.8755514916624267
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,50453,137,0.83 [0.55-1.26],0.3844630746998732
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Benign neoplasm: Stomach,50544,104,0.83 [0.51-1.34],0.4450595488912249
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Benign lipomatous neoplasm,50004,585,0.82 [0.67-1.00],0.0542423721133359
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,50460,215,0.75 [0.54-1.05],0.0892407870765467
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,50464,176,0.73 [0.50-1.06],0.0968724495634668
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",50347,104,0.68 [0.41-1.11],0.121402493314768
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Haemangioma, any site",50352,103,0.70 [0.43-1.15],0.157492263892466
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Melanocytic naevi,50190,393,0.85 [0.67-1.09],0.2062068831662199
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Melanocytic naevi of other and unspecified parts of face,50483,173,0.87 [0.60-1.25],0.4520127376643973
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Other benign neoplasms of skin,50278,361,0.92 [0.71-1.18],0.4934219071700759
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Benign neoplasm of breast,27201,135,1.32 [0.93-1.88],0.1176650814842173
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Leiomyoma of uterus,26697,995,0.83 [0.71-0.97],0.0182865517408351
CEBPB,CCAAT/enhancer-binding protein beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,47978,382,1.05 [0.83-1.32],0.7062549361066011
CEBPB,CCAAT/enhancer-binding protein beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,47364,697,0.92 [0.77-1.10],0.3549935394606549
CEBPB,CCAAT/enhancer-binding protein beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,47364,697,0.92 [0.77-1.10],0.3549935394606549
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),43646,912,1.22 [1.06-1.41],0.0073327853096628
CEBPB,CCAAT/enhancer-binding protein beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,49469,132,0.89 [0.59-1.36],0.5993877285462852
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,49938,166,1.68 [1.27-2.22],0.0002394112304129
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,40863,2334,1.07 [0.97-1.18],0.1761905990002511
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,47532,1066,1.00 [0.87-1.15],0.982519055102146
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes,45982,268,1.08 [0.82-1.42],0.5982618774708965
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Peripheral artery disease,48201,222,1.00 [0.73-1.37],0.9955368640592306
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,45953,239,1.06 [0.79-1.42],0.7013729231419623
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes,46805,1091,1.03 [0.89-1.19],0.7262139965071216
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,46769,1055,1.04 [0.90-1.20],0.6063928985144245
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,46756,366,1.07 [0.82-1.38],0.6303785396693968
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",46759,362,1.06 [0.82-1.38],0.657453549546986
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,40522,1993,1.04 [0.94-1.16],0.4365388649257488
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",38792,263,1.00 [0.75-1.33],0.9788048276241876
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,40368,1839,1.04 [0.93-1.16],0.4811765940736904
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,38626,97,1.50 [1.02-2.20],0.0376515992397823
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",38696,167,1.26 [0.91-1.74],0.1729282535601171
CEBPB,CCAAT/enhancer-binding protein beta,Chapter V Mental and behavioural disorders,Any mental disorder,42718,1281,1.03 [0.90-1.18],0.6356218961363416
CEBPB,CCAAT/enhancer-binding protein beta,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",41880,443,1.20 [0.97-1.49],0.1000202233771541
CEBPB,CCAAT/enhancer-binding protein beta,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",49748,333,1.10 [0.86-1.42],0.4470848076492297
CEBPB,CCAAT/enhancer-binding protein beta,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",49877,242,1.37 [1.04-1.81],0.0275513337861589
CEBPB,CCAAT/enhancer-binding protein beta,Chapter V Mental and behavioural disorders,Acute alcohol intoxication,47043,113,0.75 [0.47-1.19],0.2245238896610119
CEBPB,CCAAT/enhancer-binding protein beta,Chapter V Mental and behavioural disorders,"Acute alcohol intoxication, ICD10",50352,113,0.75 [0.47-1.19],0.223130948004281
CEBPB,CCAAT/enhancer-binding protein beta,Chapter V Mental and behavioural disorders,"Alcohol abuse, main dg, excluding more controls",41550,113,0.74 [0.47-1.18],0.2104863342499768
CEBPB,CCAAT/enhancer-binding protein beta,Chapter V Mental and behavioural disorders,Alcohol dependence,47066,136,1.40 [0.98-2.00],0.0658675854232442
CEBPB,CCAAT/enhancer-binding protein beta,Chapter V Mental and behavioural disorders,Smoking dependency,46960,113,1.74 [1.23-2.47],0.0017338983666963
CEBPB,CCAAT/enhancer-binding protein beta,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",41545,108,0.82 [0.51-1.30],0.3927112413185669
CEBPB,CCAAT/enhancer-binding protein beta,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",42080,643,0.89 [0.74-1.08],0.2336815198520314
CEBPB,CCAAT/enhancer-binding protein beta,Chapter V Mental and behavioural disorders,Depression,47385,561,0.88 [0.72-1.08],0.2206076862289332
CEBPB,CCAAT/enhancer-binding protein beta,Chapter V Mental and behavioural disorders,Depression or dysthymia,41582,487,0.89 [0.72-1.11],0.2891188299896164
CEBPB,CCAAT/enhancer-binding protein beta,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",41686,249,1.10 [0.83-1.46],0.5164053201088806
CEBPB,CCAAT/enhancer-binding protein beta,Chapter V Mental and behavioural disorders,Other anxiety disorders,47650,128,0.96 [0.63-1.45],0.8310005297998581
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Neurological diseases,43192,2907,0.90 [0.82-0.99],0.0289655639456821
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,39205,255,0.83 [0.62-1.13],0.2442520936148499
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,50251,204,0.80 [0.57-1.13],0.2050053483699639
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,47910,951,0.87 [0.74-1.01],0.0757197408427125
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Epilepsy,47257,298,0.54 [0.40-0.73],4.4002219208048526e-05
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Migraine,47118,159,0.91 [0.63-1.33],0.6314680477785429
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",49959,143,0.96 [0.65-1.42],0.8419965074941962
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Transient ischemic attack,48913,157,1.02 [0.71-1.48],0.9089506337078136
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Other sleep disorders,47288,329,1.21 [0.95-1.54],0.1225641393688742
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Sleep apnoea,49406,251,1.14 [0.86-1.51],0.3679024537507134
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",48242,1321,0.93 [0.81-1.06],0.26262496779061
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",47159,238,0.90 [0.66-1.22],0.4855196181230442
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,47686,765,0.94 [0.79-1.12],0.5079320280505253
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,49951,161,0.63 [0.43-0.94],0.0232757652330886
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Hemiplegia,49902,112,0.56 [0.35-0.91],0.0191540395275553
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Other neurological diseases,49569,237,0.93 [0.68-1.26],0.6316607780661531
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",49233,720,0.87 [0.72-1.04],0.1168841966615279
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,48933,420,0.81 [0.64-1.02],0.0756043233955295
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,48660,147,0.81 [0.55-1.21],0.3143265393320846
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,48750,237,0.78 [0.56-1.07],0.1162483461746593
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,48667,154,0.91 [0.62-1.34],0.6423092615014796
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,43508,316,0.99 [0.76-1.29],0.931541540433966
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,43974,782,1.05 [0.89-1.24],0.5365098818939478
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,48565,428,0.85 [0.68-1.08],0.1858933614265395
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,49877,105,1.08 [0.69-1.69],0.7224296528440071
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic maculopathy,4307,105,0.94 [0.59-1.49],0.7921711875675249
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",45675,105,1.09 [0.70-1.71],0.6963522149854486
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,49198,191,1.42 [1.06-1.91],0.0181682444943049
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,49111,104,1.44 [0.97-2.14],0.0679746378021778
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",49180,171,1.16 [0.83-1.63],0.3865048457492085
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,49466,197,0.90 [0.64-1.26],0.5386702126278278
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diseases of middle ear and mastoid,50327,257,1.01 [0.76-1.35],0.9400181335662822
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of ear,48821,203,0.84 [0.60-1.18],0.3141155766841396
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,35787,6462,1.04 [0.97-1.12],0.2827043255486186
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,49288,133,1.45 [1.04-2.04],0.0306691791840613
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"Hypertension, essential",37663,4460,1.03 [0.95-1.11],0.4720137173101072
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Hypertension,37731,4528,1.03 [0.95-1.12],0.4417977241213515
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,33357,154,1.36 [0.97-1.92],0.0741721494438298
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",46206,2360,1.08 [0.97-1.19],0.1466142095477339
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Angina pectoris,45266,1420,1.02 [0.90-1.16],0.732269672768934
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,48473,477,1.03 [0.83-1.27],0.7965351917022016
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,48941,945,1.10 [0.95-1.28],0.1971629049611589
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",50280,188,1.14 [0.82-1.58],0.4452006250282366
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",44434,588,1.08 [0.89-1.30],0.4507940870039544
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,45690,1880,1.12 [1.00-1.25],0.0474973061852832
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Pulmonary embolism,48901,219,1.37 [1.04-1.82],0.0251386820724586
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Venous thromboembolism,49110,454,1.02 [0.82-1.27],0.85876581849729
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Secondary right heart disease,48859,177,1.63 [1.24-2.16],0.0005610422559437
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,48861,179,1.63 [1.24-2.16],0.0004902786196536
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",33373,170,1.58 [1.18-2.12],0.002182830302171
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Cardiomyopathy,41907,115,1.73 [1.24-2.41],0.0012198486855843
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Conduction disorders,42037,245,1.02 [0.76-1.37],0.8717692721215307
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,27887,235,1.08 [0.80-1.46],0.6097890019010843
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,28517,865,1.15 [0.98-1.36],0.0851250482021978
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Other arrhythmias,41929,137,1.03 [0.70-1.52],0.883360075774842
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,41975,183,1.16 [0.84-1.61],0.3691003469226522
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"Heart failure, strict",48438,408,1.22 [0.98-1.52],0.0762749308779418
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",48773,313,0.84 [0.64-1.11],0.2228089125084189
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",48836,264,0.92 [0.69-1.23],0.5741096527874456
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",48989,233,0.88 [0.65-1.21],0.4374012653296889
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,48191,152,1.17 [0.82-1.68],0.3877980258236724
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,48295,256,1.11 [0.83-1.47],0.477203509193457
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),47639,279,0.81 [0.61-1.08],0.1528429949637044
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,DVT of lower extremities,47596,236,0.85 [0.62-1.17],0.3178478350623648
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",50106,225,0.85 [0.61-1.17],0.3057141914096845
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Varicose veins,48289,929,0.98 [0.84-1.15],0.8473087277157287
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Hypotension,48170,170,0.71 [0.49-1.05],0.0836606707827967
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,40292,4053,1.01 [0.93-1.09],0.8193745674194522
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,50167,212,1.07 [0.79-1.46],0.6668938180996093
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Influenza and pneumonia,46837,436,1.20 [0.98-1.48],0.0835280331101085
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",46783,382,1.26 [1.01-1.56],0.0395874854768148
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,48682,500,1.20 [0.98-1.46],0.0757372825624312
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,48671,489,1.23 [1.01-1.49],0.0435717885898148
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,48944,1203,0.87 [0.76-1.00],0.0507467482549975
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Chronic sinusitis,47925,184,0.72 [0.50-1.03],0.0737086486865964
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Nasal polyp,47984,243,1.01 [0.75-1.36],0.9578000891962178
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",48519,778,0.83 [0.69-0.98],0.0304248396503006
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Deviated nasal septum,48108,367,0.78 [0.61-1.01],0.061334656604173
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,23212,124,0.94 [0.61-1.44],0.7776778013176681
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,45145,1990,1.01 [0.91-1.12],0.8750247077756517
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Early onset COPD,48202,347,1.17 [0.92-1.49],0.187805739120543
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",48255,400,1.14 [0.91-1.43],0.2612912284840659
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,"Other chronic obstructive pulmonary disease, including avohilmo",48255,400,1.14 [0.91-1.43],0.2612912284840659
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,"Asthma, hospital admissions , main diagnosis only",47131,1643,0.99 [0.88-1.12],0.9070360015626624
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Asthma,36062,1643,1.01 [0.89-1.13],0.922132655172624
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",35542,1643,1.01 [0.90-1.13],0.9123054710951972
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",36037,1618,0.99 [0.88-1.12],0.9076212470359896
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,49808,185,1.67 [1.28-2.19],0.0001891831096478
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Interstitial lung disease,47632,142,1.77 [1.32-2.37],0.0001322637219562
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,"ILD, hospital admissions",49959,142,1.78 [1.33-2.38],0.0001175346717526
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,47618,128,1.64 [1.18-2.27],0.0030422143243426
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Pleural effusion,46435,219,0.97 [0.71-1.33],0.8640253849573797
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Other diseases of pleura,46686,470,1.18 [0.96-1.45],0.1143649505441605
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,48039,215,1.49 [1.14-1.95],0.0038150440038159
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,34359,11416,0.96 [0.91-1.02],0.1850354607068235
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",49506,823,1.00 [0.85-1.18],0.9542974353831852
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,50473,177,1.01 [0.71-1.43],0.9650885707906948
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Impacted teeth,50481,164,1.01 [0.70-1.45],0.958062577065212
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Dental caries,48896,213,1.24 [0.93-1.66],0.1472171854718341
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,48880,197,0.72 [0.50-1.02],0.064111114535813
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,50456,197,0.96 [0.69-1.34],0.8273507588717499
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,48873,190,0.89 [0.63-1.26],0.5169411557476894
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,48344,155,1.14 [0.80-1.62],0.4654622132538542
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,50310,104,1.21 [0.79-1.84],0.385130699343118
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,38432,534,1.02 [0.83-1.24],0.8769107936629966
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",42158,4260,0.93 [0.86-1.00],0.0594058618076472
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Oesophagitis,38565,667,0.90 [0.75-1.08],0.2616270350207865
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,39256,1358,0.92 [0.81-1.05],0.2206523869228734
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,38047,149,0.95 [0.64-1.39],0.7751271764604071
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,38304,406,0.86 [0.68-1.09],0.209542352926864
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Oesophageal obstruction,38010,112,0.95 [0.61-1.48],0.8136820573463541
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Gastric ulcer,38196,298,0.81 [0.61-1.07],0.1412530645762375
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Duodenal ulcer,38142,244,1.38 [1.06-1.79],0.0171099350111939
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",50268,170,1.52 [1.13-2.05],0.0061770157200933
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Chronic gastritis,38140,242,0.87 [0.64-1.19],0.3894336288470948
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),39498,1600,0.91 [0.81-1.03],0.1409415321350528
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Diseases of appendix,50224,245,0.78 [0.57-1.06],0.1164098746748752
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Functional dyspepsia,38764,866,1.03 [0.88-1.20],0.7515624141401123
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,38230,332,0.85 [0.65-1.11],0.2267328882744567
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,50220,303,1.03 [0.79-1.33],0.8526019354722347
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Acute appendicitis,50175,196,0.70 [0.49-0.99],0.0456053387684583
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Hernia,44208,3193,0.92 [0.85-1.01],0.0725209902561816
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Inguinal hernia,42183,1168,0.90 [0.78-1.03],0.131916115824697
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Umbilical hernia,41269,254,1.09 [0.83-1.44],0.5386933023919591
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Ventral hernia,41213,198,0.90 [0.64-1.26],0.5272455334783823
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,42716,1701,0.92 [0.82-1.04],0.1721925265237425
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,48608,1489,1.09 [0.97-1.23],0.1525964619655734
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other diseases of intestines,39540,3927,0.99 [0.92-1.07],0.8118726379191343
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",49866,114,1.07 [0.70-1.64],0.7448540883934593
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, require KELA, min 2 HDR)",50397,155,1.00 [0.69-1.45],0.9833160758489632
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Crohn disease,47274,155,1.00 [0.69-1.45],0.9809814856046296
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Crohn's disease NAS,47235,116,1.05 [0.68-1.60],0.8370597216522877
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,"Ulcerative colitis (strict definition, require KELA, min 2 HDR)",50268,267,1.22 [0.93-1.59],0.1505234181525138
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Ulcerative colitis,47386,267,1.22 [0.93-1.59],0.151842349227474
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",47358,239,1.32 [1.00-1.73],0.0478339524380865
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,48330,1211,1.08 [0.95-1.23],0.2405274631146631
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,48316,1197,1.08 [0.95-1.24],0.238764548196697
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,35805,192,1.00 [0.71-1.39],0.9809927283006996
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Intestinal stricture,49622,192,1.02 [0.73-1.42],0.9259382208058772
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",35739,126,1.16 [0.79-1.72],0.4490362468414253
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,36805,1192,1.08 [0.95-1.24],0.2340509353420828
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,35936,323,0.89 [0.68-1.16],0.3886627635810623
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,36182,569,1.07 [0.89-1.30],0.4615796154424295
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Constipation,47305,510,1.09 [0.90-1.33],0.3798992786380136
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Diseases of peritoneum,49658,170,1.13 [0.80-1.58],0.4960098265206563
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,35892,279,0.99 [0.75-1.31],0.951120151945696
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,35752,139,1.00 [0.67-1.47],0.9804681801729276
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,37331,1718,0.93 [0.83-1.05],0.2436870997898034
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other diseases of intestine,36151,538,1.01 [0.83-1.23],0.9118029821391792
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,49630,142,1.25 [0.87-1.78],0.2229807765796364
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Diseases of liver,48931,244,1.17 [0.88-1.55],0.2723897533758874
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other diseases of liver,48821,134,1.08 [0.73-1.59],0.7021109884033765
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",47836,1230,1.05 [0.92-1.20],0.4347259431588347
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Cholelithiasis,47597,991,1.08 [0.94-1.25],0.281960883940341
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Cholecystitis,46801,195,1.23 [0.90-1.68],0.1837806282401284
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,46706,100,1.06 [0.67-1.67],0.8053092813633763
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Acute pancreatitis,46736,130,1.19 [0.81-1.76],0.3720848457617531
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Acute pancreatitis (for exclusion),50189,130,1.19 [0.81-1.75],0.3787872053267337
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Diseases of the digestive system,47813,618,1.26 [1.06-1.50],0.0094980449922325
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Intestinal malabsorption,47337,142,0.84 [0.56-1.27],0.4050025767621376
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Coeliac disease,47311,116,0.93 [0.60-1.44],0.7394346717904005
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",47293,98,1.24 [0.80-1.92],0.3413536112093139
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,47584,389,1.38 [1.11-1.70],0.0030338200104761
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,GI-bleeding,47570,375,1.36 [1.10-1.69],0.0048842629480649
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,44325,3051,0.96 [0.88-1.05],0.3534212164201057
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,49635,198,1.12 [0.82-1.54],0.4675006497426157
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,49703,893,0.89 [0.76-1.05],0.1713730946382454
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,47391,1135,0.92 [0.80-1.06],0.2390203211366417
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,48751,776,0.94 [0.80-1.12],0.5009532443356368
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",48150,175,0.83 [0.58-1.20],0.3295246529032458
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,48472,497,0.99 [0.80-1.22],0.9396994483744774
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,49978,177,1.25 [0.91-1.73],0.1691977636158576
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,49937,136,1.25 [0.87-1.80],0.2325672536529947
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,49904,103,1.29 [0.85-1.95],0.231769978547784
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,49957,110,1.14 [0.75-1.74],0.5449472016954134
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,49952,105,1.06 [0.68-1.65],0.8134880724312955
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,48922,112,0.67 [0.42-1.08],0.0997405145598003
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,49524,714,0.94 [0.78-1.12],0.4667937301364336
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,46443,187,0.93 [0.66-1.32],0.7016024926007322
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,46451,195,0.66 [0.46-0.95],0.0246080402715953
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,46405,149,0.67 [0.44-1.01],0.0571118737892724
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",46683,427,1.05 [0.84-1.31],0.6714133135239742
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,46635,379,1.03 [0.82-1.31],0.7849023705899949
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,36362,7839,0.94 [0.89-1.00],0.0664045688212882
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,39541,4552,0.96 [0.89-1.04],0.3015104527082
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,45549,2386,0.88 [0.80-0.97],0.012064056253417
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,35286,297,1.13 [0.87-1.46],0.3643337860170228
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,35911,922,1.01 [0.87-1.18],0.88131406338919
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",49698,285,1.09 [0.83-1.42],0.5330856150116848
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,49722,260,1.09 [0.82-1.44],0.5442017421747682
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,37252,2263,0.97 [0.87-1.07],0.545740618487924
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Artrosis, including avohilmo",42316,2263,0.97 [0.88-1.08],0.6207611585250186
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,35129,140,0.78 [0.52-1.18],0.2385586616937641
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",49395,136,0.85 [0.56-1.28],0.4351784296471086
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,35432,443,0.97 [0.78-1.22],0.8081728308391558
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,35133,144,0.81 [0.54-1.23],0.3265417175879062
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,35549,560,1.03 [0.85-1.26],0.7467072416258502
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",50219,277,1.08 [0.82-1.42],0.5946738519626257
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,36027,1038,1.00 [0.86-1.16],0.9833637455440278
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,35770,781,0.88 [0.74-1.05],0.1558209313409048
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,37517,2528,0.95 [0.87-1.05],0.3370333761298066
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),35117,128,0.79 [0.51-1.23],0.2989578771545764
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),35454,465,0.95 [0.76-1.19],0.6543632003309643
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,35099,110,1.03 [0.66-1.61],0.888433288450876
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),35105,116,1.33 [0.90-1.96],0.1536513245428451
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,35935,946,0.96 [0.83-1.12],0.6388978897770254
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,35806,817,0.99 [0.84-1.16],0.8593804564730663
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,39087,551,0.94 [0.76-1.15],0.5227478216123618
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,49446,252,0.89 [0.66-1.21],0.467290809816215
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,49304,110,1.09 [0.71-1.68],0.6853028292926266
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,43638,123,0.73 [0.47-1.14],0.1702870461774425
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,44094,579,0.89 [0.73-1.09],0.2713160119399944
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,45346,1831,1.01 [0.90-1.13],0.8868115246074382
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,43885,370,0.99 [0.77-1.26],0.9248250828495388
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,43680,165,0.76 [0.52-1.11],0.1580954679862253
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",44961,1446,1.05 [0.93-1.19],0.3885410672910281
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,43614,99,0.78 [0.48-1.28],0.3207681243740541
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,43978,463,1.07 [0.87-1.32],0.5310382348621296
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,43711,196,1.06 [0.77-1.47],0.7178748803025483
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,43670,155,1.25 [0.89-1.77],0.1990967655341309
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,43793,278,1.15 [0.88-1.50],0.292488921967862
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,43640,125,1.02 [0.67-1.53],0.9434756392118756
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,44124,609,1.14 [0.95-1.37],0.1557548181371828
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,43779,616,0.79 [0.65-0.96],0.017936839197837
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,43297,134,0.93 [0.62-1.39],0.7124587356360499
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,43335,172,0.73 [0.50-1.07],0.1037140575721227
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,43366,203,0.79 [0.56-1.11],0.1774586191955596
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",43259,96,1.19 [0.77-1.85],0.4285863071444106
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,43391,228,0.90 [0.65-1.23],0.5107999231466264
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],43364,201,1.15 [0.84-1.58],0.3904852022819958
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,43685,522,0.93 [0.76-1.15],0.5211665457025062
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,43270,107,1.07 [0.69-1.65],0.7657427563248949
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,43319,156,1.09 [0.76-1.57],0.6348326764380161
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,43412,249,0.79 [0.58-1.07],0.1297806152636974
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,43285,122,0.63 [0.40-0.99],0.0455672220197254
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",44041,878,0.84 [0.71-0.99],0.0345020324582574
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,43491,328,0.77 [0.59-1.02],0.0645987820408134
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,43638,475,0.82 [0.65-1.02],0.0750172902124401
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,46794,337,1.06 [0.83-1.36],0.6462535746194821
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,47227,770,0.97 [0.82-1.15],0.7513894264139487
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,46552,95,1.25 [0.80-1.94],0.3318178888903493
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,46572,115,0.82 [0.52-1.28],0.3809283783701025
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,46660,203,0.85 [0.61-1.19],0.336511934882076
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,40075,8393,1.00 [0.95-1.06],0.9212708806017312
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,20049,1262,1.02 [0.89-1.17],0.7504806053738888
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,45338,497,1.41 [1.17-1.70],0.0002444246841005
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,44975,134,1.21 [0.82-1.77],0.3323809837097026
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Acute renal failure,45540,109,1.92 [1.39-2.64],7.30227004237527e-05
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,45567,136,1.37 [0.95-1.96],0.0894650229682467
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,45563,132,1.83 [1.35-2.48],9.84808406442438e-05
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Urolithiasis,49798,482,1.26 [1.03-1.53],0.0213272587357227
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,49644,140,1.27 [0.89-1.82],0.1835579769053255
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,49659,343,1.24 [0.98-1.56],0.0754596372789326
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,49487,171,1.24 [0.89-1.72],0.198110563668038
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,46166,2056,0.99 [0.89-1.10],0.8696489594181944
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Cystitis,44305,195,0.99 [0.71-1.38],0.9466829205689976
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,44266,156,0.77 [0.52-1.15],0.2081418776405209
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,44649,539,0.94 [0.77-1.16],0.5756869210053347
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Urethral stricture,44339,229,0.93 [0.68-1.28],0.6698250976753295
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,45446,1336,1.02 [0.90-1.16],0.7433299626604417
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,19348,561,1.12 [0.92-1.36],0.253966032770782
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),18891,104,0.87 [0.55-1.39],0.5683153700748734
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Hydrocele,18883,96,0.96 [0.60-1.54],0.8615373483266172
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",18947,160,1.08 [0.75-1.55],0.6751657750307234
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,18945,158,1.06 [0.73-1.52],0.7640502973809207
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,19001,214,0.92 [0.67-1.28],0.6266392105693614
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Disorders of breast,26940,475,1.22 [1.00-1.49],0.0482709529770382
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,26613,148,0.66 [0.44-1.01],0.0542075512239393
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Unspecified lump in breast,26633,168,1.52 [1.15-2.02],0.0036248598745541
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,26575,110,1.48 [1.03-2.12],0.0346513063505857
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,26876,550,0.89 [0.73-1.10],0.2791725138778987
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Inflammatory disease of cervix uteri,26459,133,0.83 [0.55-1.27],0.397564327616035
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,26573,247,0.94 [0.70-1.27],0.6786456233944846
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,24820,4531,0.92 [0.85-0.99],0.0320174177829168
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Endometriosis,20650,361,0.70 [0.54-0.91],0.0078196009724592
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Unspecified/other endometriosis,20388,99,0.87 [0.54-1.40],0.5596237240206126
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),20454,165,0.49 [0.33-0.74],0.0005900129460145
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,21063,774,0.85 [0.71-1.02],0.0777146643430233
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,20691,402,0.78 [0.61-0.99],0.0442769338922548
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,21231,942,0.97 [0.83-1.13],0.6750239385090164
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Uterine polyps,20602,313,0.80 [0.60-1.06],0.1135858854937743
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",20725,436,0.75 [0.59-0.95],0.0159423002366997
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Erosion and ectropion of cervix uteri,20387,98,1.28 [0.85-1.93],0.2457215206765589
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Dysplasia of cervi uteri,20475,186,0.82 [0.57-1.17],0.2655491354674678
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,"All dysplastic lesions of the cervix uteri, vagina or vulva",27217,266,0.88 [0.65-1.18],0.3892790134007831
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,All dysplastic lesions of the cervix uteri,27228,252,0.87 [0.65-1.18],0.383993705815825
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,HSIL lesion of the cervix uteri,27253,138,0.98 [0.66-1.46],0.9343889290361306
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",27243,152,1.00 [0.69-1.46],0.9973406170253598
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,20431,142,0.89 [0.60-1.33],0.5831147483732408
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,20402,113,0.53 [0.33-0.87],0.0109402720424048
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,20425,136,1.16 [0.80-1.68],0.4270394408288517
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Irregular menses,27147,464,1.04 [0.84-1.28],0.7454873424289736
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",21623,1334,0.92 [0.81-1.05],0.2290459208503065
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Menorrhagia,21162,873,0.83 [0.70-0.98],0.0268356290780905
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",27233,194,1.22 [0.90-1.66],0.204593718736468
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,20742,453,0.78 [0.61-0.98],0.0318481928503008
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,20611,322,0.97 [0.75-1.26],0.8290437951294425
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,21180,891,0.98 [0.84-1.15],0.8254494887743438
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Female infertility,20403,114,0.95 [0.61-1.47],0.8171943571266757
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,"Female infertility, cervigal, vaginal, other or unspecified origin",20396,107,0.89 [0.56-1.41],0.6079824855786036
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,27250,862,0.84 [0.70-1.00],0.0530645846498027
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter XV Pregnancy, childbirth and the puerperium",Complications of labour and delivery,27256,1182,0.74 [0.63-0.87],0.0003412862777532
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy with abortive outcome,27250,469,1.03 [0.82-1.28],0.812952072667789
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter XV Pregnancy, childbirth and the puerperium",Other abnormal products of conception,26918,137,0.82 [0.54-1.25],0.3510512501538763
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter XV Pregnancy, childbirth and the puerperium",Spontaneous abortion,26965,184,1.05 [0.75-1.48],0.7679991295643103
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter XV Pregnancy, childbirth and the puerperium",Medical abortion,26945,164,1.20 [0.85-1.71],0.3035533774074026
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter XV Pregnancy, childbirth and the puerperium","Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium",27270,167,0.86 [0.59-1.25],0.4367249951379671
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy hypertension,27272,164,0.83 [0.57-1.22],0.3524063614170687
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter XV Pregnancy, childbirth and the puerperium",Other maternal disorders predominantly related to pregnancy,27267,410,0.82 [0.64-1.05],0.1080204520457823
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter XV Pregnancy, childbirth and the puerperium",Haemorrhage in early pregnancy,26981,124,0.98 [0.64-1.50],0.9419652889999994
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other conditions predominantly related to pregnancy,27084,227,0.81 [0.58-1.12],0.2063506102126959
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected malpresentation of fetus,26532,144,0.84 [0.56-1.27],0.4104058054983772
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected abnormality of pelvic organs,26585,197,0.93 [0.66-1.31],0.6632531058329487
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other known or suspected fetal problems,26633,245,0.79 [0.57-1.09],0.1507840005243428
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter XV Pregnancy, childbirth and the puerperium",Premature rupture of membranes,26534,146,0.95 [0.64-1.42],0.8180278222494727
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter XV Pregnancy, childbirth and the puerperium",False labour,26523,135,0.79 [0.52-1.22],0.2914232951284079
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter XV Pregnancy, childbirth and the puerperium",Prolonged pregnancy,26536,148,0.70 [0.46-1.07],0.099428799439536
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter XV Pregnancy, childbirth and the puerperium",Long labour,26304,230,0.55 [0.38-0.78],0.0007741220667734
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter XV Pregnancy, childbirth and the puerperium",Labour and delivery complicated by fetal stress [distress],26502,428,0.70 [0.55-0.91],0.0066582911737125
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter XV Pregnancy, childbirth and the puerperium",Perineal laceration during delivery,26733,659,0.81 [0.66-1.00],0.0461808261986761
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter XV Pregnancy, childbirth and the puerperium","Postpartum hemorraghe, all women as controls",27271,171,0.69 [0.47-1.01],0.0548726539137115
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter XV Pregnancy, childbirth and the puerperium",Postpartum haemorrhage due to anatomy,25844,129,0.59 [0.37-0.93],0.0227025299992364
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter XV Pregnancy, childbirth and the puerperium","Other complications of labour and delivery, not elsewhere classified",26178,104,0.64 [0.39-1.05],0.0788552080814965
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter XV Pregnancy, childbirth and the puerperium",Delivery,27279,331,0.72 [0.54-0.95],0.0204704500287986
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter XV Pregnancy, childbirth and the puerperium",Single spontaneous delivery,27198,250,0.66 [0.47-0.91],0.0108801374054635
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter XV Pregnancy, childbirth and the puerperium","Other obstetric conditions, not elsewhere classified",27266,247,0.97 [0.71-1.32],0.8448608839719309
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter XV Pregnancy, childbirth and the puerperium","Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium",27256,237,0.94 [0.69-1.29],0.7209676811512654
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",49745,118,1.13 [0.75-1.71],0.5457184136729214
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Falls/tendency to fall,45514,1178,0.98 [0.85-1.12],0.7636393706625282
